HAVANA, Cuba (acn) A new pentavalent vaccine (Heberpenta) to combat diphtheria, tetanus, whooping cough, hepatitis B, and Haemophilus influenza B, is already being used in Cuba, announced on Wednesday the director of Technological Development of the Havana-based Center of Genetic Engineering and Biotechnology (CIGB), Eduardo Martinez Diaz.">HAVANA, Cuba (acn) A new pentavalent vaccine (Heberpenta) to combat diphtheria, tetanus, whooping cough, hepatitis B, and Haemophilus influenza B, is already being used in Cuba, announced on Wednesday the director of Technological Development of the Havana-based Center of Genetic Engineering and Biotechnology (CIGB), Eduardo Martinez Diaz.">

Cuba Headlines

Cuba News, Breaking News, Articles and Daily Information

Cuba Implements Nationwide Use of New Pentavalent Vaccine

  • Submitted by: manso
  • 08 / 22 / 2011

HAVANA, Cuba (acn) A new pentavalent vaccine (Heberpenta) to combat diphtheria, tetanus, whooping cough, hepatitis B, and Haemophilus influenza B, is already being used in Cuba, announced on Wednesday the director of Technological Development of the Havana-based Center of Genetic Engineering and Biotechnology (CIGB), Eduardo Martinez Diaz.

According to Granma newspaper, the new product, registered in 2010, was produced by researchers of the CIGB with the participation of specialists from the Finlay Institute, the National Center of Bio-Products, the Pedro Kouri Institute of Tropical Medicine, and other Cuban scientific institutions.

Martinez explained that this is an improved and easier-to-administer version of a product registered in 2006. Unlike its predecessor, the new vaccine combines all the antigens in the same container. This reduces production, transportation and storage costs and leads to a 25% increase of the number of vaccines produced with the same volume of antigens.Thus far, only three countries around the world produce a similar vaccine.

Related News

Comments